1.
Kachhadia MP, Puri P, Patel K, et al. Sodium-Glucose Co-Transporter 2 Inhibitor Use and Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis and Type 2 Diabetes: A Retrospective Observational Cohort Study Using Real-World Data. J Clin Med Res. 2026;18(5):313-325. doi:10.14740/jocmr6577